Multicellular Ovarian Cancer Model for Evaluation of Nanovector Delivery in Ascites and Metastatic Environments
A novel multicellular model composed of epithelial ovarian cancer and fibroblast cells was developed as an in vitro platform to evaluate nanovector delivery and ultimately aid the development of targeted therapies. We hypothesized that the inclusion of peptide-based scaffold (PuraMatrix) in the sphe...
Enregistré dans:
Auteurs principaux: | Stephen J. Winter, Hunter A. Miller, Jill M. Steinbach-Rankins |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/aea05537f23f4bd7bb6de5e15a3ccf0d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Exploration of Benzenesulfonamide-Bearing Imidazole Derivatives Activity in Triple-Negative Breast Cancer and Melanoma 2D and 3D Cell Cultures
par: Benas Balandis, et autres
Publié: (2021) -
miRNA Delivery by Nanosystems: State of the Art and Perspectives
par: Fernanda C. Moraes, et autres
Publié: (2021) -
Molecular characteristics and tumorigenicity of ascites‐derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer
par: Yi Ding, et autres
Publié: (2021) -
Development of Breast Cancer Spheroids to Evaluate Cytotoxic Response to an Anticancer Peptide
par: Marco Cavaco, et autres
Publié: (2021) -
Nanotechnology-Based Delivery Systems for Antimicrobial Peptides
par: Adewale Oluwaseun Fadaka, et autres
Publié: (2021)